Advertisement

Human Gastric Neuroendocrine Neoplasia: Current Pathologic Status

  • Guido Rindi
  • Enrico Solcia

Introduction

This chapter provides an overview of nonneoplastic (hyperplasia and dysplasia) and neoplastic endocrine cell lesions of the stomach [the carcinoid, or well-differentiated (neuro)endocrine tumor/carcinoma, and the poorly differentiated endocrine carcinoma, (PDEC)]. The normal endocrine cell counterparts are also briefly described.

The adjective “neuroendocrine” is widely used for this type of tumor and is considered a synonym of “endocrine,” as defined by the World Health Organization (WHO) which also maintains the traditional term “carcinoid.” All of these various tumor-connoting definitions are used synonymously throughout this chapter.

The Gastric Endocrine Cells

Five different endocrine cell types are described in the gastric mucosa of humans (Table 6.1) (Rindi et al. 2002a; Simonsson et al. 1988; Solcia et al. 1975, 2000a). The most represented endocrine cell type of the oxyntic mucosa is the histamine-producing, entero-chromaffin-like (ECL) cell (Figure 6.1A)....

Keywords

Endocrine Cell Gastric Carcinoid Endocrine Cell Growth Oxyntic Mucosa Endocrine Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abraham, S.C., Carney, J.A., Ooi, A., Choti, M.A., and Argani, P. (2005). Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder. Am J Surg Pathol. 29:969–75.CrossRefPubMedGoogle Scholar
  2. Annibale, B., Azzoni, C., Corleto, V. D., di Giulio, E., Caruana, P., D'Ambra, G., Bordi, C., and Delle Fave, G. (2001). Atrophic body gastritis patients with enterochromaffin-like cell dyspla-sia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol. 13:1449–56.CrossRefPubMedGoogle Scholar
  3. Arnold, R., Frank, M., Simon, B., Eissele, R., and Koop, H. (1992). Adaptation and renewal of the endocrine stomach. Scand J Gastroenterol Suppl. 193:20–7.CrossRefPubMedGoogle Scholar
  4. Arnold, R., Hulst, M.V., Neuhof, C.H., Schwarting, H., Becker, H.D., and Creutzfeldt, W. (1982). Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut. 23:285–91.CrossRefPubMedGoogle Scholar
  5. Borch, K., Ahren, B., Ahlman, H., Falkmer, S., Granerus, G., and Grimelius, L. (2005). Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg. 242:64–73.CrossRefPubMedGoogle Scholar
  6. Borch, K., Renvall, H., and Liedberg, G. (1985). Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 88:638–48.PubMedGoogle Scholar
  7. Bordi, C., Azzoni, C., Ferraro, G., Corleto, V.D., Gibril, F., Delle Fave, G., Lubensky, I.A., Venzon, D.J., and Jensen, R.T. (2000). Sampling strategies for analysis of enterochromaffin-like cell changes in Zollinger-Ellison syndrome. Am J Clin Pathol. 114:419–25.PubMedGoogle Scholar
  8. Bordi, C., Cocconi, G., Togni, R., Vezzadini, P., and Missale, G. (1974). Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol. 98:274–8.PubMedGoogle Scholar
  9. Bordi, C., Corleto, V.D., Azzoni, C., Pizzi, S., Ferraro, G., Gibril, F., Delle Fave, G., and Jensen, R.T. (2001). The antral mucosa as a new site for endocrine tumors in multiple endocrine neo-plasia type 1 and Zollinger-Ellison syndromes. J Clin Endocrinol Metab. 86:2236–42.CrossRefPubMedGoogle Scholar
  10. Bordi, C., D'Adda, T., Azzoni, C., Pilato, F.P., and Caruana, P. (1995). Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol. 19 Suppl 1:S8–19.PubMedGoogle Scholar
  11. Bordi, C., Falchetti, A., Azzoni, C., D'Adda, T., Canavese, G., Guariglia, A., Santini, D., Tomassetti, P., and Brandi, M.L. (1997). Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol. 21:1075–82.CrossRefPubMedGoogle Scholar
  12. Bordi, C., Ferrari, C., D'Adda, T., Pilato, F., Carfagna, G., Bertele, A., and Missale, G. (1986). Ultrastructural characterization of fundic endocrine cell hyperplasia associated with atrophic gastritis and hypergastrinaemia. Virchows Arch A Pathol Anat Histopathol. 409:335–47.CrossRefPubMedGoogle Scholar
  13. Bordi, C., Gabrielli, M., and Missale, G. (1978). Pathologic changes of endocrine cells in chronic atrophic gastritis. An ultrastructural study on peroral gastric biopsy specimens. Arch Pathol Lab Med. 102:129–35.PubMedGoogle Scholar
  14. Bordi, C., Yu, J.Y., Baggi, M.T., Davoli, C., Pilato, F.P., Baruzzi, G., Gardini, G., Zamboni, G., Franzin, G., Papotti, M., and Bussolati, G. (1991). Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer. 67:663–72.CrossRefPubMedGoogle Scholar
  15. Brenner, B., Tang, L.H., Klimstra, D.S., and Kelsen, D.P. (2004). Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 22:2730–9.CrossRefPubMedGoogle Scholar
  16. Brenner, B., Tang, L.H., Shia, J., Klimstra, D.S., and Kelsen, D.P. (2007). Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Semin Oncol. 34:43–50.CrossRefPubMedGoogle Scholar
  17. Cadiot, G., Lehy, T., Ruszniewski, P., Bonfils, S., and Mignon, M. (1993). Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci. 38:1307–17.CrossRefPubMedGoogle Scholar
  18. Cadiot, G., Vissuzaine, C., Potet, F., and Mignon, M. (1995). Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome. Dig Dis Sci. 40:1275–8.CrossRefPubMedGoogle Scholar
  19. Capella, C., Finzi, G., Cornaggia, M., Usellini, L., Luinetti, O., and Buffa, R. (1991). Ultrastructural typing of gastric endocrine cells. In The stomach as an endocrine organ, R. Håkanson and F. Sundler eds, 27–51. Amsterdam: Elsevier.Google Scholar
  20. Capella, C., Heitz, P.U., Hofler, H., Solcia, E., and Kloppel, G. (1995). Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 425:547–60.CrossRefPubMedGoogle Scholar
  21. Carney, J.A., Go, V.L., Fairbanks, V.F., Moore, S.B., Alport, E.C., and Nora, F.E. (1983). The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med. 99:761–6.PubMedGoogle Scholar
  22. Creutzfeldt, W. (1988). The achlorhydria-carcinoid sequence: role of gastrin. Digestion. 39:61–79.PubMedGoogle Scholar
  23. D'Adda, T., Corleto, V., Pilato, F.P., Baggi, M.T., Robutti, F., Delle Fave, G., and Bordi, C. (1990). Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology. 99:17–26.PubMedGoogle Scholar
  24. Dixon, M.F., Genta, R.M., Yardley, J.H., and Correa, P. (1996). Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 20:1161–81.CrossRefPubMedGoogle Scholar
  25. Eissele, R., Brunner, G., Simon, B., Solcia, E., and Arnold, R. (1997). Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology. 112:707–17.CrossRefPubMedGoogle Scholar
  26. Feurle, G.E. (1994). Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut. 35:275–7.CrossRefPubMedGoogle Scholar
  27. Feyrter, F., and Klima, R. (1952). Uber die Histopathologie der Magenveranderungen bei der Anaemia perniciosa. Munch Med Wochenschr. 94:145–53.PubMedGoogle Scholar
  28. Friesen, S.R., and Tomita, T. (1981). Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor. Ann Surg. 194:481–93.CrossRefPubMedGoogle Scholar
  29. Gould, V.E., Jao, W., Chejfec, G., Banner, B.F., and Bonomi, P. (1984). Neuroendocrine carcinomas of the gastrointestinal tract. Semin Diagn Pathol. 1:13–18.PubMedGoogle Scholar
  30. Håkanson, E., Ekelund, M., and Sundler, F. (1984). Activation and proliferation of gastric endocrine cells. In volution and tumor pathology of the neuroendocrine system, S. Falkmer, R. Hakanson and F. Sundler eds, 371–98. Amsterdam: Elsevier.Google Scholar
  31. Hamilton, S.R., and Aaltonen, L.A. (eds). (2000). World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. IARC Press, Lyon.Google Scholar
  32. Hemminki, K., and Li, X. (2001). Incidence trends and risk factors of carcinoid tumors: a nation wide epidemiologic study from Sweden. Cancer. 92:2204–10.CrossRefPubMedGoogle Scholar
  33. Hirschowitz, B.I., Griffith, J., Pellegrin, D., and Cummings, O.W. (1992). Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology. 102:1409–18.PubMedGoogle Scholar
  34. Hodgson, N., Koniaris, L.G., Livingstone, A.S., and Franceschi, D. (2005). Gastric carcinoids: a temporal increase with proton pump introduction. Surg Endosc. 19:1610–2.CrossRefPubMedGoogle Scholar
  35. Holle, G.E., Spann, W., Eisenmenger, W., Riedel, J., and Pradayrol, L. (1986). Diffuse somatostatin-immunoreactive D-cell hyperplasia in the stomach and duodenum. Gastroenterology. 91:733–9.PubMedGoogle Scholar
  36. Hou, W., and Schubert, M.L. (2007). Treatment of gastric carcinoids. Curr Treat Options Gastroenterol. 10:123–33.CrossRefPubMedGoogle Scholar
  37. Hsing, A.W., Hansson, L.E., McLaughlin, J.K., Nyren, O., Blot, W.J., Ekbom, A., and Fraumeni, J.F., Jr. (1993). Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer. 71:745–50.CrossRefPubMedGoogle Scholar
  38. Jensen, R.T. (2006). Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol. 98:4–19.CrossRefPubMedGoogle Scholar
  39. Keuppens, F., Willems, G., De Graef, J., and Woussen-Colle, M.C. (1980). Antral gastrin cell hyperplasia in patients with peptic ulcer. Ann Surg. 191:276–81.CrossRefPubMedGoogle Scholar
  40. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:656–60.CrossRefPubMedGoogle Scholar
  41. Kokkola, A., Sjoblom, S.M., Haapiainen, R., Sipponen, P., Puolakkainen, P., and Jarvinen, H. (1998). The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol. 33:88–92.CrossRefPubMedGoogle Scholar
  42. Lamberts, R., Creutzfeldt, W., Struber, H.G., Brunner, G., and Solcia, E. (1993). Long-term ome-prazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology. 104:1356–70.PubMedGoogle Scholar
  43. Lampert, I.A., Thorpe, P., Van Noorden, S., Marsh, J., Goldman, J.M., Gordon-Smith, E.C., and Evans, D.J. (1985). Selective sparing of enterochromaffin cells in graft versus host disease affecting the colonic mucosa. Histopathology. 9:875–866.CrossRefPubMedGoogle Scholar
  44. Larsson, L.I., Ljungberg, O., Sundler, F., Hakanson, R., Svensson, S.O., Rehfeld, J., Stadil, R., and Holst, J. (1973). Antor-pyloric gastrinoma associated with pancreatic nesidioblastosis and proliferation of islets. Virchows Arch A Pathol Pathol Anat. 360:305–14.CrossRefPubMedGoogle Scholar
  45. Lehy, T., Cadiot, G., Mignon, M., Ruszniewski, P., and Bonfils, S. (1992). Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut. 33:1275–9.CrossRefPubMedGoogle Scholar
  46. Lehy, T., Mignon, M., Cadiot, G., Elouaer-Blanc, L., Ruszniewski, P., Lewin, M.J., and Bonfils, S. (1989). Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology. 96:1029–40.PubMedGoogle Scholar
  47. Liu, Y., Vosmaer, G.D., Tytgat, G.N., Xiao, S.D., and Ten Kate, F.J. (2005). Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis. J Clin Pathol. 58:927–31.CrossRefPubMedGoogle Scholar
  48. Maggard, M.A., O'Connell, J.B., and Ko, C.Y. (2004). Updated population-based review of car-cinoid tumors. Ann Surg. 240:117–22.CrossRefPubMedGoogle Scholar
  49. Mizuma, K., Shibuya, H., Totsuka, M., and Hayasaka, H. (1983). Carcinoid of the stomach: a case report and review of 100 cases reported in Japan. Ann Chir Gynaecol. 72:23–7.PubMedGoogle Scholar
  50. Modlin, I.M., Kidd, M., Latich, I., Zikusoka, M.N., and Shapiro, M.D. (2005). Current status of gastrointestinal carcinoids. Gastroenterology. 128:1717–51.CrossRefPubMedGoogle Scholar
  51. Modlin, I.M., Lye, K.D., and Kidd, M. (2003). A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 97:934–59.CrossRefPubMedGoogle Scholar
  52. Modlin, I.M., Lye, K.D., and Kidd, M. (2004). A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol. 99:23–32.CrossRefPubMedGoogle Scholar
  53. Nishi, T., Makuuchi, H., and Weinstein, W.M. (2005). Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus. Tokai J Exp Clin Med. 30:117–21.PubMedGoogle Scholar
  54. Oderda, G., Fiocca, R., Villani, L., Altare, F., Morra, I., and Ansaldi, N.S. (1993). Gastrin cell hyperplasia in childood Helicobacter Pylori gastritis. Eur J Gastroenterol Hepatol. 5:13–6.CrossRefGoogle Scholar
  55. Ooi, A., Ota, M., Katsuda, S., Nakanishi, I., Sugawara, H., and Takahashi, I. (1995). An Unusual Case of Multiple Gastric Carcinoids Associated with Diffuse Endocrine Cell Hyperplasia and Parietal Cell Hypertrophy. Endocr Pathol. 6:229–237.CrossRefPubMedGoogle Scholar
  56. Papotti, M., Cassoni, P., Volante, M., Deghenghi, R., Muccioli, G., and Ghigo, E. (2001). Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab. 86:5052–9.CrossRefPubMedGoogle Scholar
  57. Peghini, P.L., Annibale, B., Azzoni, C., Milione, M., Corleto, V.D., Gibril, F., Venzon, D.J., Delle Fave, G., Bordi, C., and Jensen, R.T. (2002). Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology. 123:68–85.CrossRefPubMedGoogle Scholar
  58. Polak, J.M., Stagg, B., and Pearse, A.G. (1972). Two types of Zollinger-Ellison syndrome: immunofluorescent, cytochemical and ultrastructural studies of the antral and pancreatic gastrin cells in different clinical states. Gut. 13:501–12.CrossRefPubMedGoogle Scholar
  59. Quinonez, G., Ragbeer, M.S., and Simon, G.T. (1988). A carcinoid tumor of the stomach with features of a midgut tumor. Arch Pathol Lab Med. 112:838–41.PubMedGoogle Scholar
  60. Rappel, S., Altendorf-Hofmann, A., and Stolte, M. (1995). Prognosis of gastric carcinoid tumours. Digestion. 56:455–62.CrossRefPubMedGoogle Scholar
  61. Richards, A.T., Hinder, R.A., and Harrison, A.C. (1987). Gastric carcinoid tumours associated with hypergastrinaemia and pernicious anaemia—regression of tumors by antrectomy. A case report. S Afr Med J. 72:51–3.Google Scholar
  62. Rindi, G., Annibale, B., Bonamico, M., Corleto, V., Delle Fave, G., and Solcia, E. (1994). Helicobacter pylori infection in children with antral gastrin cell hyperfunction. J Pediatr Gastroenterol Nutr. 18:152–8.CrossRefPubMedGoogle Scholar
  63. Rindi, G., Azzoni, C., La Rosa, S., Klersy, C., Paolotti, D., Rappel, S., Stolte, M., Capella, C., Bordi, C., and Solcia, E. (1999). ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 116:532–42.CrossRefPubMedGoogle Scholar
  64. Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., and Solcia, E. (1996). Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 20:168–72.CrossRefPubMedGoogle Scholar
  65. Rindi, G., Kloppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W.W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., Korner, M., Lopes, J.M., McNicol, A.M., Nilsson, O., Perren, A., Scarpa, A., Scoazec, J.Y., and Wiedenmann, B. (2006). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 449:395–401.CrossRefPubMedGoogle Scholar
  66. Rindi, G., Luinetti, O., Cornaggia, M., Capella, C., and Solcia, E. (1993). Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 104:994–1006.PubMedGoogle Scholar
  67. Rindi, G., Necchi, V., Savio, A., Torsello, A., Zoli, M., Locatelli, V., Raimondo, F., Cocchi, D., and Solcia, E. (2002a). Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochem Cell Biol. 117:511–9.CrossRefGoogle Scholar
  68. Rindi, G., Paolotti, D., Fiocca, R., Wiedenmann, B., Henry, J.P., and Solcia, E. (2000). Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors. Virchows Arch. 436:217–23.CrossRefPubMedGoogle Scholar
  69. Rindi, G., Savio, A., Torsello, A., Zoli, M., Locatelli, V., Cocchi, D., Paolotti, D., and Solcia, E. (2002b). Ghrelin expression in gut endocrine growths. Histochem Cell Biol. 117:521–5.CrossRefGoogle Scholar
  70. Roucayrol, A.M., and Cattan, D. (1990). Evolution of fundic argyrophil cell hyperplasia in non-antral atrophic gastritis. Gastroenterology. 99:1307–14.PubMedGoogle Scholar
  71. Rubin, W. (1973). A fine structural characterization of the proliferated endocrine cells in atrophic gastric mucosa. Am J Pathol. 70:109–18.PubMedGoogle Scholar
  72. Ruszniewski, P., Delle Fave, G., Cadiot, G., Komminoth, P., Chung, D., Kos-Kudla, B., Kianmanesh, R., Hochhauser, D., Arnold, R., Ahlman, H., Pauwels, S., Kwekkeboom, D.J., and Rindi, G. (2006). Well-differentiated gastric tumors/carcinomas. Neuroendocrinology. 84:158–64.CrossRefPubMedGoogle Scholar
  73. Safatle-Ribeiro, A.V., Ribeiro, U., Jr., Corbett, C.E., Iriya, K., Kobata, C.H., Sakai, P., Yagi, O.K., Pinto, P.E., Jr., Zilberstein, B., and Gama-Rodrigues, J. (2007). Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors. Eur J Gastroenterol Hepatol. 19:21–8.CrossRefPubMedGoogle Scholar
  74. Simonsson, M., Eriksson, S., Hakanson, R., Lind, T., Lonroth, H., Lundell, L., O'Connor, D.T., and Sundler, F. (1988). Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol. 23:1089–99.CrossRefPubMedGoogle Scholar
  75. Sjoblom, S.M., Sipponen, P., Miettinen, M., Karonen, S.L., and Jrvinen, H.J. (1988). Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy. 20:52–6.CrossRefPubMedGoogle Scholar
  76. Sobin, L.H., and Wittekind, C. (eds). (2002). TNM Classification of malignant tumours. Wiley-Liss, New York-Toronto.Google Scholar
  77. Solcia, E., Bordi, C., Creutzfeldt, W., Dayal, Y., Dayan, A.D., Falkmer, S., Grimelius, L., and Havu, N. (1988). Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 41:185–200.CrossRefPubMedGoogle Scholar
  78. Solcia, E., Capella, C., and Vassallo, G. (1970). Endocrine cells of the stomach and pancreas in states of gastric hypersecretion. Rendic R Gastroenterol. 2:147–158.Google Scholar
  79. Solcia, E., Capella, C., Buffa, R., Fiocca, R., Frigerio, B., and Usellini, L. (1980). Identification, ultrastructure and classification of gut endocrine cells and related growths. Invest Cell Pathol. 3:37–49.PubMedGoogle Scholar
  80. Solcia, E., Capella, C., Buffa, R., Usellini, L., Frigerio, B., and Fontana, P. (1979). Endocrine cells of the gastrointestinal tract and related tumors. Pathobiol Annu. 9:163–204.PubMedGoogle Scholar
  81. Solcia, E., Capella, C., Fiocca, R., Rindi, G., and Rosai, J. (1990). Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol. 14:503–13.CrossRefPubMedGoogle Scholar
  82. Solcia, E., Capella, C., Fiocca, R., Sessa, F., LaRosa, S., and Rindi, G. (1998). Disorders of the endocrine system. In Pathology of the gastrointestinal tract., S. C. Ming and H. Goldman eds, 295–322. Philadelphia: Williams and Wilkins.Google Scholar
  83. Solcia, E., Capella, C., Sessa, F., Rindi, G., Cornaggia, M., Riva, C., and Villani, L. (1986). Gastric carcinoids and related endocrine growths. Digestion. 35 Suppl 1:3–22.CrossRefPubMedGoogle Scholar
  84. Solcia, E., Capella, C., Vassallo, G., and Buffa, R. (1975). Endocrine cells of the gastric mucosa. Int Rev Cytol. 42:223–86.CrossRefPubMedGoogle Scholar
  85. Solcia, E., Fiocca, R., Sessa, F., Rindi, G., Gianatti, A., Cornaggia, M., and Capella, C. (1991a). Morphology and natural history of gastric endocrine tumors. In The stomach as an endocrine organ, R. Håkanson and F. Sundler eds, 473–498. Amsterdam: Elsevier.Google Scholar
  86. Solcia, E., Fiocca, R., Villani, L., Gianatti, A., Cornaggia, M., Chiaravalli, A., Curzio, M., and Capella, C. (1991b). Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol Suppl. 180:146–59.CrossRefGoogle Scholar
  87. Solcia, E., Fiocca, R., Villani, L., Luinetti, O., and Capella, C. (1995). Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. Am J Surg Pathol. 19 Suppl 1:S1–7.CrossRefPubMedGoogle Scholar
  88. Solcia, E., Klöppel, G., and Sobin, L. H. (2000b). Histological typing of endocrine tumours. Springer-Verlag, New York.Google Scholar
  89. Solcia, E., Rindi, G., Buffa, R., Fiocca, R., and Capella, C. (2000a). Gastric endocrine cells: types, function and growth. Regul Pept. 93:31–5.CrossRefGoogle Scholar
  90. Solcia, E., Rindi, G., Fiocca, R., Villani, L., Buffa, R., Ambrosiani, L., and Capella, C. (1992). Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med. 65:793–804; discussion 827–9.PubMedGoogle Scholar
  91. Srivastava, A., Kamath, A., Barry, S.A., and Dayal, Y. (2004). Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells. Endocr Pathol. 15:47–54.CrossRefPubMedGoogle Scholar
  92. Sweeney, E.C., and McDonnell, L.M. (1980). Atypical gastric carcinoids. Histopathology. 4:215–24.CrossRefPubMedGoogle Scholar
  93. Tartaglia, A., Vezzadini, C., Bianchini, S., and Vezzadini, P. (2005). Gastrinoma of the stomach: a case report. Int J Gastrointest Cancer. 35:211–6.CrossRefPubMedGoogle Scholar
  94. Tsolakis, A.V., Portela-Gomes, G.M., Stridsberg, M., Grimelius, L., Sundin, A., Eriksson, B.K., Oberg, K.E., and Janson, E.T. (2004). Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab. 89:3739–44.CrossRefPubMedGoogle Scholar
  95. Wangberg, B., Grimelius, L., Granerus, G., Conradi, N., Jansson, S., and Ahlman, H. (1990). The role of gastric resection in the management of multicentric argyrophil gastric carcinoids. Surgery. 108:851–7.PubMedGoogle Scholar
  96. Ye, W., and Nyren, O. (2003). Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut. 52:938–41.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Guido Rindi
    • 1
  • Enrico Solcia
    • 2
  1. 1.Dipartimento di Patologia e Medicina di LaboratorioSezione di Anatomia Patologica, Universita' degli StudiParmaItaly
  2. 2.Dipartimento di Patologia Umana ed EreditariaSezione di Anatomia Patologica, Universiti PaviaPavisItaly

Personalised recommendations